Inventor
DUMOUTIER LAURE
BE12 patents
⚠️ This page may combine multiple inventors who share the name “DUMOUTIER LAURE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LUDWIG INST CANCER RES
4 patentsUS6274710B1Aug 14, 2001
Antibodies which specifically bind T Cell inducible factors (TIFs)
LUDWIG INST CANCER RES94 citations97
US6359117B1Mar 19, 2002
Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and uses therefor
LUDWIG INST CANCER RES73 citations94
US7033787B2Apr 25, 2006
Isolated cytokine receptor LICR-2
LUDWIG INST CANCER RES13 citations79
US7081528B2Jul 25, 2006
Isolated nucleic acid molecules encoding T cell derived inducible factors
LUDWIG INST CANCER RES10 citations72
LUDWIG INST FOR CANCER RES LTD
3 patentsUS10000572B2Jun 19, 2018
Method for inhibiting the immune suppressive function of human T regulatory cells by administering an anti-GARP monoclonal antibody
LUDWIG INST FOR CANCER RES LTD22 citations92
US11230603B2Jan 25, 2022
Anti-GARP protein
LUDWIG INST FOR CANCER RES LTD0 citations60
US10604579B2Mar 31, 2020
Antibody against a complex between human GARP and latent TGF-β
LUDWIG INST FOR CANCER RES LTD0 citations50
WYETH CORP
3 patentsUS7268223B2Sep 11, 2007
Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
WYETH CORP2 citations62
US7569667B2Aug 4, 2009
Isolated soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
WYETH CORP1 citations51
US7846652B2Dec 7, 2010
Method for identifying a substance which mediates interaction between interleukin 22 and an interleukin 22 receptor
WYETH CORP0 citations45